Holen Sie sich die Stockscreener-App
1.18
1.67%
-0.02
Handel nachbörslich:
1.18
Schlusskurs vom Vortag:
$1.20
Offen:
$1.2
24-Stunden-Volumen:
246.55K
Relative Volume:
0.45
Marktkapitalisierung:
$17.53M
Einnahmen:
$43.20M
Nettoeinkommen (Verlust:
$-11.09M
KGV:
-1.0642
EPS:
-1.1088
Netto-Cashflow:
$-9.32M
1W Leistung:
-10.61%
1M Leistung:
-21.85%
6M Leistung:
+43.29%
1J Leistung:
+22.90%
1-Tages-Spanne:
$1.16
$1.23
1-Wochen-Bereich:
$1.11
$1.32
52-Wochen-Spanne:
$0.5547
$1.66
Biofrontera Inc Stock (BFRI) Company Profile
Firmenname
Biofrontera Inc
Sektor
Telefon
781-245-1325
Adresse
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, TEVA, HLN, ZTS, VTRS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
1.18 | 17.53M | 43.20M | -11.09M | -9.32M | -1.1088 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Biofrontera Inc Aktie (BFRI) Neueste Nachrichten
Biofrontera Inc.Warrants (Nasdaq:BFRIW) Detailed Stock Data - The Chronicle-Journal
Biofrontera stock gets FDA approval for skin cancer treatment By Investing.com - Investing.com Australia
Biofrontera stock gets FDA approval for skin cancer treatment - Investing.com
Biofrontera Wins FDA Approval for Ameluz in Superficial Basal Cell Carcinoma - Minichart
Form 8K Biofrontera Inc For: 14 September By Investing.com - Investing.com Nigeria
Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use - TipRanks
Biofrontera wins FDA approval for Ameluz to treat skin cancer - Investing.com
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma - GlobeNewswire
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerSynthetic Long - dars.gov.et
Biofrontera (NASDAQ:BFRI) Passes Minervini Trend Template With High-Growth Momentum - ChartMill
Biofrontera Inc. Warrants (BFRIW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Biofrontera Inc. Warrants (BFRIW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BFRI Q2 2026 Earnings: Loss Narrows Sharply, Delivering 53% EPS BeatEarnings Acceleration Picks - vinanet.vn
Biofrontera Inc. Warrants (BFRIW) Peer Comparison – Compare with Others - Value Research
Biofrontera (BFRI) Jumps 6.71% to $1.59, Testing Key Resistance Near $1.67Common Gap - vinanet.vn
Biofrontera Inc. Warrants (BFRIW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biofrontera (BFRI) Quarterly Figures: Profit Per Share Clears Its Benchmark on the Day; Share Move: Shares Show Little Net Change in Latest TradingRevenue Inflection Point - vinanet.vn
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - AOL.com
Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayCall Spread Alert - vinanet.vn
Ziopharm: Q2 Earnings Snapshot - AOL.com
Biofrontera (BFRI) Climbs 3.17% to $1.30: Holding Above Key Support ZonePCR Divergence - vinanet.vn
Biofrontera Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Biofrontera Q2 2026 Earnings Call Transcript - marketbeat.com
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ... - Yahoo Finance
Biofrontera Inc. (BFRI) lifts revenue yet flags going concern and ITC impact - Stock Titan
Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BFRI Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 6.4% Stock RallyEarnings Weakness Phase - vinanet.vn
Same Patent, Same Light- Director Vacates IPR Decision at Odds With ITC Decision - The National Law Review
Biofrontera earnings beat by $0.09, revenue topped estimates - Investing.com
Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6% - Investing.com
BFRI: Record revenue growth, margin expansion, and strong pipeline offset ITC lamp restriction - TradingView
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Australia
BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings - Quiver Quantitative
Biofrontera Reports Q2 2026 Revenue Up 33% to $12.0M, Gross Margin 80% - TradingView
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - The Manila Times
Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker - Stock Titan
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside - Yahoo Finance
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Se - GuruFocus
Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeMAMA Signal - dars.gov.et
Biofrontera Inc. (BFRI) Stock Major Holders - Yahoo! Finance Canada
Price to sales forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biofrontera Inc. (BFRI) stock price, news, quote and history - Yahoo Finance Singapore
BFRI Q1 2026 Earnings: EPS Misses Estimates by 215%, Shares Edge Down 0.8%CEO Earnings Statement - careplusvn.com
BFRI Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - The Manila Times
Biofrontera schedules Aug. 13 webcast for business update - Stock Titan
Biofrontera (BFRI) Q1 2026 Earnings: Deep EPS Miss Reflects Rising Costs and Pipeline PressureEarnings Preview - careplusvn.com
Finanzdaten der Biofrontera Inc-Aktie (BFRI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):